Estimated impact of the COVID-19 pandemic on cancer services and excess 1-year mortality in people with cancer and multimorbidity: near real-time data on cancer care, cancer deaths and a population-based cohort study

Registry study (database of 3,862,012 adults in England) found declines of 70.4% for urgent referrals for cancer, & 41.5% for chemotherapy attendances during the pandemic. There were also short term excess death registrations for cancer (peak RR of 1.17 at week ending 3rd April).

BMJ Open